Brief: Akoya Biosciences Q2 EPS USD -0.51
07/08/2023 21:05
Aug 07 (Reuters) - Akoya Biosciences Q2 revenue USD 23.5 million vs. IBES estimate USD 22.4 million. * outlook FY revenue USD 95-98 million
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks